Whole blood components are collected from UK donors as described in Chapter 5. These components undergo primary processing to separate the blood constituents into red cell, platelet, granulocyte and plasma components.
Currently in the UK whole blood components are not routinely used for transfusion, although provisional component specifications for use in clinical trials are described in Annexe 3.